Huang Guizhong, Xi Pu, Yao Zehui, Zhao Chongyu, Li Xiaohui, Chen Zexian, Lin Xiaojun
Department of Pancreatobiliary Surgery, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, People's Republic of China.
Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Army Medical University, Chongqing, 400037, People's Republic of China.
J Inflamm Res. 2024 May 7;17:2787-2799. doi: 10.2147/JIR.S460103. eCollection 2024.
Intrahepatic cholangiocarcinoma (ICC) correlates with poor outcomes, necessitating the identification of prognostic factors from an inflammation-nutritional perspective in locally advanced ICC patients after R0 resection.
We retrospectively reviewed the medical records of 159 locally advanced ICC patients from Sun Yat-sen University Cancer Center. Univariate and multivariate Cox regression analysis, as well as competing risk analysis, were conducted to explore prognostic variables for locally advanced ICC following surgery. To validate the robustness of our findings, we performed propensity score matching (PSM) analyses to evaluate survival differences based on inflammation-nutritional indexes.
Considering non-cancer-specific death as competing risk factors, both systemic immune-inflammation index (SII, HR: 1.934) and prognostic nutrition index (PNI, HR: 0.604) emerged as significant prognostic variables for locally advanced ICC after R0 resection (P < 0.05). After PSM, the survival benefit between the low and high PNI sets remained clear (median survival time: 15.7 months vs 35.1 months, P = 0.002). Although the 5-year overall survival (OS) rate of the low SII group was higher than that of the high SII group, the difference was not statistically significant (17.5% VS 27.4%, P = 0.112). Other influencing factors included tumor number, tumor diameter, preoperative carcinoembryonic antigen (CEA)and carbohydrate antigen 19-9 (CA19-9) levels, and postoperative adjuvant therapy.
Individual inflammatory and nutritional status significantly impact the prognosis of locally advanced ICC undergoing R0 hapectomy. Oncologists should consider incorporating inflammation-nutritional conditions into the decision-making process for this subset of advanced ICC.
肝内胆管癌(ICC)与不良预后相关,因此有必要从炎症-营养角度识别R0切除术后局部晚期ICC患者的预后因素。
我们回顾性分析了中山大学肿瘤防治中心159例局部晚期ICC患者的病历。进行单因素和多因素Cox回归分析以及竞争风险分析,以探索局部晚期ICC术后的预后变量。为验证我们研究结果的稳健性,我们进行了倾向评分匹配(PSM)分析,以评估基于炎症-营养指标的生存差异。
将非癌症特异性死亡视为竞争风险因素,全身免疫炎症指数(SII,HR:1.934)和预后营养指数(PNI,HR:0.604)均成为R0切除术后局部晚期ICC的显著预后变量(P<0.05)。PSM后,低PNI组和高PNI组之间的生存获益仍然明显(中位生存时间:15.7个月对35.1个月,P=0.002)。虽然低SII组的5年总生存率高于高SII组,但差异无统计学意义(17.5%对27.4%,P=0.112)。其他影响因素包括肿瘤数量、肿瘤直径、术前癌胚抗原(CEA)和糖类抗原19-9(CA19-9)水平以及术后辅助治疗。
个体炎症和营养状态显著影响接受R0肝切除术的局部晚期ICC的预后。肿瘤学家应考虑将炎症-营养状况纳入这部分晚期ICC的决策过程。